Status:

NOT_YET_RECRUITING

Non-invasive Personalized Transcranial Cortical Neurostimulation for Pain Relief

Lead Sponsor:

Hospices Civils de Lyon

Conditions:

Drug-resistant Neuropathic Pain

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Neuropathic pain is a public health problem with less than 50% of patients being relieved by drug treatments. Surgically implanted motor cortex stimulation represents an invasive therapeutic solution...

Eligibility Criteria

Inclusion

  • Aged 18 to 80 years
  • Neuropathic pain of more than one year's duration1
  • Failed treatment with tricyclic or tetracyclic antidepressants, antiepileptics and a combination of morphine and a serotonin (5HT) norepinephrine (NA2) reuptake inhibitor, in the absence of contraindication.
  • Average pain intensity of at least 4/10 in the month preceding the inclusion visit.
  • Recipient or beneficiary of a social security scheme-

Exclusion

  • Chronic non-neuropathic pain or pain associated with progressive pathology, active epilepsy, unhealed scalp wound, impaired comprehension or communication that prevents subjective daily and weekly assessments.
  • Active epilepsy, treated or not
  • Unhealed scalp wound adjacent to EEG recording electrodes or transcranial stimulation application (contraindication to Medical Device (DM) use)
  • Pregnant or breast-feeding women
  • Inability to understand or follow the ins and outs of the study, in particular the need to assess pain intensity on a daily basis or to trace it, possibly with the help of a third party (comprehension or communication disorders).
  • People under guardianship, curatorship or legal protection
  • Persons deprived of their liberty, persons under psychiatric care and persons admitted to a health or social establishment for purposes other than clinical investigation
  • Participation in other research interfering with the present study.

Key Trial Info

Start Date :

September 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2029

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06209645

Start Date

September 1 2024

End Date

March 1 2029

Last Update

April 17 2024

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.